Get started
Inventiva SAInventiva SAInventiva SA

Inventiva SA

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsForecastSeasonals

6IV chart


Full chart

6IV upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪636.51 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.080 EUR
Net income (FY)
‪−184.21 M‬ EUR
Revenue (FY)
‪9.20 M‬ EUR
Shares float
‪84.90 M‬
Beta (1Y)
0.46

Employees


Employees (FY)
119
Change (1Y)
−4 −3.25%
Revenue / Employee (1Y)
‪77.29 K‬ EUR
Net income / Employee (1Y)
‪−1.55 M‬ EUR

About Inventiva SA


Sector
Health Technology
Industry
Biotechnology
CEO
Frédéric Cren
Website
inventivapharma.com
Headquarters
Daix
Founded
2011
ISIN
FR0013233012
FIGI
BBG00G25Q7V2
Inventiva SA is a clinical-stage biopharmaceutical company, which focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis, or NASH, and other diseases with significant unmet medical need. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centered on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.

Check out other big names from the same industry as 6IV.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

6IV news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 6IV is 4.300 EUR — it has increased by 2.50% in the past 24 hours. Watch Inventiva SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Inventiva SA stocks are traded under the ticker 6IV.
6IV stock has fallen by −4.97% compared to the previous week, the month change is a 19.28% rise, over the last year Inventiva SA has showed a 118.05% increase.
We've gathered analysts' opinions on Inventiva SA future price: according to them, 6IV price has a max estimate of 22.31 EUR and a min estimate of 4.80 EUR. Watch 6IV chart and read a more detailed Inventiva SA stock forecast: see what analysts think of Inventiva SA and suggest that you do with its stocks.
6IV reached its all-time high on Jan 22, 2021 with the price of 15.580 EUR, and its all-time low was 1.450 EUR and was reached on Oct 9, 2024. View more price dynamics on 6IV chart.
See other stocks reaching their highest and lowest prices.
6IV stock is 2.44% volatile and has beta coefficient of 0.46. Track Inventiva SA stock price on the chart and check out the list of the most volatile stocks — is Inventiva SA there?
Today Inventiva SA has the market capitalization of ‪637.10 M‬, it has decreased by −7.29% over the last week.
Yes, you can track Inventiva SA financials in yearly and quarterly reports right on TradingView.
Inventiva SA is going to release the next earnings report on Sep 25, 2025. Keep track of upcoming events with our Earnings Calendar.
6IV earnings for the last half-year are −2.00 EUR per share, whereas the estimation was −0.72 EUR, resulting in a −178.59% surprise. The estimated earnings for the next half-year are −0.54 EUR per share. See more details about Inventiva SA earnings.
Inventiva SA revenue for the last half-year amounts to ‪10.12 M‬ EUR, despite the estimated figure of ‪6.11 M‬ EUR. In the next half-year revenue is expected to reach ‪4.50 M‬ EUR.
6IV net income for the last half-year is ‪−135.18 M‬ EUR, while the previous report showed ‪−49.03 M‬ EUR of net income which accounts for −175.72% change. Track more Inventiva SA financial stats to get the full picture.
No, 6IV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 21, 2025, the company has 119 employees. See our rating of the largest employees — is Inventiva SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Inventiva SA EBITDA is ‪−95.89 M‬ EUR, and current EBITDA margin is ‪−1.04 K‬%. See more stats in Inventiva SA financial statements.
Like other stocks, 6IV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Inventiva SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Inventiva SA technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Inventiva SA stock shows the buy signal. See more of Inventiva SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.